Nanovibronix Stock Insider Trading

Healthcare > Medical - Devices

Buy NAOV

*Your capital is at risk

$4.02

+0 (+0%)

At Close: Mar 13, 2026

NanoVibronix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 892K and sold 189.98K NAOV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	892K shares
● Sell	189.98K shares
45% Buy Activity Moderate Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Cassirer Aurora Director	Director	2 500 Value: $22.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Cassirer Aurora Director	Director	2 500 Value: $22.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Ferguson Michael Director	Director	2 875 Value: $25.7K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Ferguson Michael Director	Director	2 875 Value: $58.1K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Ferguson Michael Director	Director	4 250 Value: $71.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Ferguson Michael Director	Director	1 750 Value: $25.2K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Jacob Harold Chief Medical Officer	Officer	2 500 Value: $50.5K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Brown Stephen Russell Chief Financial Officer	C-Suite Officer	2 500 Value: $36.0K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Brown Stephen Russell Chief Financial Officer	C-Suite Officer	5 000 Value: $101.0K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Brown Stephen Russell Chief Financial Officer	C-Suite Officer	2 500 Value: $42.0K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Brown Stephen Russell Chief Financial Officer	C-Suite Officer	563 Value: $5K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Jacob Harold Chief Medical Officer	Officer	2 500 Value: $22.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	4 575 Value: $235.2K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	2 500 Value: $22.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	2 500 Value: $50.5K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	3 000 Value: $50.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	1 500 Value: $21.6K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Goldstein Martin M Director	Director	1 125 Value: $36.0K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Schroeder Maria Director	Director	2 500 Value: $22.4K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	3 000 Value: $60.6K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	4 500 Value: $75.6K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	2 000 Value: $28.8K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	3 000 Value: $26.8K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	1 500 Value: $48.0K
Nov 29, 2023 Sell	Option to Purchase Common Stock D-Return	Mika Thomas Director	Director	3 000 Value: $60.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NANOVIBRONIX, INC

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter...

Read Full Profile Here